| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/29/2008 | US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity |
| 01/29/2008 | US7323472 Antiarthritic agents; sepsis shock; malaria; antiischemic agents; respiratory system disorders; brain disorders; congestive heart failure |
| 01/29/2008 | US7323471 Administering azathioprine, 6-mercaptopurine, or 6-thioguanine nucleotide, or their salts for treating graft-versus-host disease of the mouth; oral rinse |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323460 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as HIV integrase inhibitors |
| 01/29/2008 | US7323457 Containing a perhydro-4-benzodiazepinylphenyl group 1-substituted with a methylaminoacetyl-, 4-piperidinylcarbonyl- or 2-pyrrolidinylcarbonyl- group: 4-(Piperidin-4-yl)carbonyl-1-{[2-(2-benzofuranoyl)amino]-4-[1-aminocarbonyl-2-(2-naphthyl)ethylamino]carbonylaminophenyl}homopiperazine; osteoporosis |
| 01/29/2008 | US7323456 Carboxylic acid derivatives compounds and agents comprising the compounds as active ingredient |
| 01/29/2008 | US7323455 1,2,3,5-Tetrahydro-4,1-benzoxazepine derivatives: 4-methyl-5-(5-methyl-2-oxo-5-phenyl-1,2,3,5-tetrahydro-4,1-benzoxazepin-7-yl)thiophene-2-carbonitrile; contraceptives; hormone replacement therapy |
| 01/29/2008 | US7323453 Administering substituted (beta -D-ribofuranosyl)purines or (beta -D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidines alone or incombination with cidofovir, ribavirin, levovirin, or viramidine, particularly against vaccinia virus or variola virus infections |
| 01/29/2008 | US7323316 Glycosyltransferase inhibitors |
| 01/29/2008 | US7323174 Modulation of immune response and methods based thereon |
| 01/29/2008 | US7323165 Production of pancreatic islet cells and delivery of insulin |
| 01/29/2008 | CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids |
| 01/29/2008 | CA2417607C Lipase inhibitors for the treatment of dyspepsia |
| 01/29/2008 | CA2417455C Novel cyclooxygenase variants and methods of use |
| 01/29/2008 | CA2342634C Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative |
| 01/29/2008 | CA2323458C Metal chelators for use in the treatment of alzheimer's disease |
| 01/29/2008 | CA2311423C Method for treating hyperlipidemia |
| 01/29/2008 | CA2294347C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/29/2008 | CA2136120C Treatment of incontinence |
| 01/24/2008 | WO2008011636A2 Targeted gene delivery for dendritic cell vaccination |
| 01/24/2008 | WO2008011176A2 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/24/2008 | WO2008011174A2 Jak inhibitors for treatment of myeloproliferative disorders |
| 01/24/2008 | WO2008011173A2 Improvement of arginase levels/activity |
| 01/24/2008 | WO2008011085A1 Compositions and methods for the treatment of mucositis |
| 01/24/2008 | WO2008010511A1 Screening method |
| 01/24/2008 | WO2008010481A1 Aminoindan derivative or salt thereof |
| 01/24/2008 | WO2008010448A1 Novel crystal of substituted phenylalkanoic acid and production process |
| 01/24/2008 | WO2008010362A1 Powder of vitamin e/proline complex and method of producing the same |
| 01/24/2008 | WO2008010324A1 12-deoxyfusicoccin derivative and cell differentiation-inducing agent containing the same as active ingredient |
| 01/24/2008 | WO2008010315A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | WO2008010188A2 Antimicrobial and pesticidal compositions and methods comprising reduced monoterpene oil extracted from myrtaceae |
| 01/24/2008 | WO2008009639A2 New indications for direct thrombin inhibitors |
| 01/24/2008 | WO2008009638A2 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/24/2008 | WO2007100894A3 Fluvastatin sodium novel forms and preparation therof |
| 01/24/2008 | US20080022422 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/24/2008 | US20080021202 For use in diagnosis and therapy of disease; screening for antagonists and agonists of Apop proteins |
| 01/24/2008 | US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/24/2008 | US20080021196 Inhibitors of memapsin 2 and use thereof |
| 01/24/2008 | US20080021116 Pyruvate-kinase as a novel target molecule |
| 01/24/2008 | US20080021110 Producing (-)-gossypol acetic acid co-crystals from (-)-gossypol acetone co-crystals, by substituting acetone in (-)-gossypol acetone co-crystals with acetic acid; use of gossypol acetic acid co-crystals and (-)-gossypol acetic acid co-crystals for inducing and for sensitizing cells to apoptosis |
| 01/24/2008 | US20080021105 Medicine Capable of Inhibiting Activation of Transcription Factor Klf5 |
| 01/24/2008 | US20080021097 Arginase levels/activity |
| 01/24/2008 | US20080021088 Retinoid Derivatives With Antiangiogenic, Antitumoral And Proapoptotic Activities |
| 01/24/2008 | US20080021087 Carbamoylamino-substituted 2,3-dihydro-benzofurans, indoles and benzothiophenes, e.g., (+)-N-((3R)-3-(4-isopropylphenyl)-4,6,7-trimethyl-2,3-dihydro-1-benzofuran-5-yl)-3,3-dimethylbutanamide; cerebrovascular disorders |
| 01/24/2008 | US20080021066 Iap inhibitors |
| 01/24/2008 | US20080021060 Quinuclidine carbamate derivatives and their use as M3 antagonists |
| 01/24/2008 | US20080021055 Novel cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/24/2008 | US20080021035 Myosin light chain kinase inhibitor compounds, compostions and related methods of use |
| 01/24/2008 | US20080021025 Inhibitors of cathepsin s |
| 01/24/2008 | US20080021015 Use as medicine of a compound restoring active principles in vivo |
| 01/24/2008 | US20080021014 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 01/24/2008 | US20080021008 An interpenetrating polymer network preferably of a poly(C1-C4 alkyl (meth)acrylate) bulk polymer and a polyoxyalkylene glycol homopolymer or copolymer additive; controlled release coatings |
| 01/24/2008 | US20080021007 Substituted Porphyrins |
| 01/24/2008 | US20080020997 Glucosamine and Glucosamine/Anti-Inflammatory Mutual Prodrugs, Compositions, and Methods |
| 01/24/2008 | US20080020990 Oligo Double-Stranded Rna Inhibiting the Expression of Bcl-2 and Pharmaceutical Composition Containing the Same |
| 01/24/2008 | US20080020988 Brain cell- or nerve cell-protecting agents comprising medicinal ginseng |
| 01/24/2008 | US20080020981 Non-nucleoside reverse transcriptase inhibitors |
| 01/24/2008 | US20080020979 Peptides of Syndecan-1 For Inhibiting Angiogenesis |
| 01/24/2008 | US20080020978 CGRP peptide antagonists and conjugates |
| 01/24/2008 | US20080020973 Assays for identification of topoisomerase inhibitors |
| 01/24/2008 | US20080020965 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080020458 Culture system for rapid expansion of human embryonic stem cells |
| 01/24/2008 | US20080020406 Antibodies to a human Kchannel and therapeutic applications thereof |
| 01/24/2008 | US20080020070 Citrus Fruit Skin Extract for Angiogenesis Promotion |
| 01/24/2008 | US20080020058 One or more short interfering RNA, 3-dimethylamino-2-(cholest-5-en-3-beta-oxybutan-4-oxy)-1-(cis,cis-9,12-octadecadienoxy) propane, distearoyl phosphatidylcholine, cholesterol, and 1-[8'-(1,2-Dimyristoyl-3-propanoxy)-carboxamido-3',6'-dioxaoctanyl]carbamoyl-omega-methyl-polyethylene glycol; transfection |
| 01/24/2008 | US20080020053 Solid Dosage Form Comprising Proton Pump Inhibitor and Suspension Made Thereof |
| 01/24/2008 | US20080020042 Dosage form of sodium ibuprofen |
| 01/24/2008 | US20080020035 Micronutrient formulations and related methods of manufacture |
| 01/24/2008 | US20080020022 Chewable co-enzyme q-10 capsule |
| 01/24/2008 | US20080020021 5-Hydroxysapogenin derivatives with anti-dementia activity |
| 01/24/2008 | US20080020011 Therapeutic implant |
| 01/24/2008 | US20080019998 Targeted gene delivery for dendritic cell vaccination |
| 01/24/2008 | US20080019997 Therapeutic uses of dunaliella powder |
| 01/24/2008 | US20080019995 Diagnostic Assay For Trypanosoma Cruzi Infection |
| 01/24/2008 | US20080019990 Therapeutic binding agents against MUC-1 antigen and methods for their use |
| 01/24/2008 | US20080019985 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex |
| 01/24/2008 | US20080019981 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 01/24/2008 | US20080019980 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 01/24/2008 | US20080019968 Detection, prevention and treatment of breast cancer |
| 01/24/2008 | US20080019967 Inflammatory mediator antagonists |
| 01/24/2008 | US20080019966 monoclonal antibodies, hybridomas; immunoglobulins, fab fragments |
| 01/24/2008 | US20080019963 Antibodies, polypeptides and uses thereof |
| 01/24/2008 | US20080019962 Endotheliase-2 ligands |
| 01/24/2008 | US20080019953 contacting a myocardial cells with genetic engineered mammalian cells modified to express a connexin 43 proteins, to establishing electrical coupling between cardiomyocytes and recombinant cells; treatment of cardiac disease or tissue repair |
| 01/24/2008 | US20080019952 Novel Method for the Preparation of Embryoid Bodies (Ebs) and Uses Thereof |
| 01/24/2008 | US20080019916 Methods and pharmaceuticals for treating muscle insulin resistance and related conditions |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | US20080019908 Novel amphiphilic substance, and drug delivery system and molecular imaging system using the same |
| 01/24/2008 | DE60128472T2 Kombinierte tumortherapie auf der basis von distamycin-acryloylderivaten und alkylierungsmitteln Combined tumor therapy on the basis of distamycin acryloylderivaten and alkylating agents |
| 01/24/2008 | DE10121982B4 Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung Nanoparticles of protein with coupled apolipoprotein E to cross the blood-brain barrier and method for their preparation |
| 01/24/2008 | CA2658361A1 Ophthalmic formulations for the treatment of inflammation |
| 01/24/2008 | CA2658342A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/24/2008 | CA2658192A1 Jak inhibitors for treatment of myeloproliferative disorders |
| 01/24/2008 | CA2657269A1 New indications for direct thrombin inhibitors |
| 01/24/2008 | CA2657266A1 New indications for direct thrombin inhibitors in the cardiovascular field |
| 01/23/2008 | EP1880995A1 Method for producing indole derivative having piperidine ring |
| 01/23/2008 | EP1880993A1 Nitrogen-containing heterocyclic compound |